908 Devices (MASS) Liabilities and Shareholders Equity (2020 - 2026)

908 Devices (MASS) reported Liabilities and Shareholders Equity of $186.7 million for Q1 2026, down 4.76% year-over-year from $196.0 million in Q1 2025, and down 1.78% quarter-over-quarter from $190.1 million in Q4 2025.

908 Devices (MASS) Liabilities and Shareholders Equity (2020 - 2026) Analysis & Trends

908 Devices (MASS) has 7 years of Liabilities and Shareholders Equity data on file, last reported at $186.7 million in Q1 2026.

  • Liabilities and Shareholders Equity for Q1 2026 came in at $186.7 million, down 4.76% year-over-year; the trailing twelve-month figure through Mar 2026 was $759.3 million (up 2.26% YoY), and the FY2025 annual result was $190.1 million, up 19.18% from the prior year.
  • Liabilities and Shareholders Equity retreated to $186.7 million in Q1 2026 per MASS's latest filing, from $190.1 million in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $251.2 million in Q1 2022 and troughed at $159.5 million in Q4 2024.
  • A 5-year average of $207.2 million and a median of $203.0 million in 2023 frame the typical range for Liabilities and Shareholders Equity.
  • The sharpest annual moves came in 2022 and 2024: Liabilities and Shareholders Equity jumped 49.9% in 2022, then retreated 21.43% in 2024.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $242.6 million in 2022, then decreased by 16.33% to $203.0 million in 2023, then dropped by 21.43% to $159.5 million in 2024, then grew by 19.18% to $190.1 million in 2025, then retreated by 1.78% to $186.7 million in 2026.
  • Business Quant data shows MASS's Liabilities and Shareholders Equity at $186.7 million in Q1 2026, $190.1 million in Q4 2025, and $190.9 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 152.92 Bn 146.27 Bn 6.27 Bn 110.43 Bn
2 Stryker 119.50 Bn 116.62 Bn 3.81 Bn 46.29 Bn
3 Medtronic 102.71 Bn 94.54 Bn 5.76 Bn 91.49 Bn
4 Boston Scientific 69.72 Bn 68.51 Bn 3.61 Bn 44.35 Bn
5 Edwards Lifesciences 49.24 Bn 45.57 Bn 1.29 Bn 13.32 Bn
6 GE HealthCare Technologies 29.74 Bn 27.67 Bn 1.98 Bn 37.13 Bn
7 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 31.92 Bn
8 Dexcom 28.96 Bn 27.84 Bn 750.30 Mn 6.63 Bn
9 Steris 20.31 Bn 19.88 Bn 697.10 Mn 10.74 Bn
10 908 Devices 304.12 Mn 192.38 Mn 6.88 Mn 186.70 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 186.70 Mn
Dec 31, 2025 190.07 Mn
Sep 30, 2025 190.87 Mn
Jun 30, 2025 191.70 Mn
Mar 31, 2025 196.03 Mn
Dec 31, 2024 159.48 Mn
Sep 30, 2024 178.28 Mn
Jun 30, 2024 208.77 Mn
Mar 31, 2024 189.79 Mn
Dec 31, 2023 202.98 Mn
Sep 30, 2023 208.48 Mn
Jun 30, 2023 210.83 Mn
Mar 31, 2023 218.41 Mn
Dec 31, 2022 242.59 Mn
Sep 30, 2022 249.28 Mn
Jun 30, 2022 247.00 Mn
Mar 31, 2022 251.23 Mn
Dec 31, 2021 260.91 Mn
Sep 30, 2021 166.30 Mn
Jun 30, 2021 166.48 Mn